Lv5
900 积分 2022-05-11 加入
Focused update: Guidelines of care for the management of atopic dermatitis in adults
2个月前
已完结
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer
3个月前
已完结
A New Approach to Simplifying and Harmonizing Cancer Clinical Trials—Standardizing Eligibility Criteria
3个月前
已完结
Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials
5个月前
已完结
Open-label, phase II study of talimogene laherparepvec plus pembrolizumab for the treatment of advanced melanoma that progressed on prior anti-PD-1 therapy: MASTERKEY-115
6个月前
已完结
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer
1年前
已完结
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
1年前
已完结
Targeting KRAS in cancer
1年前
已完结
Emerging targeted therapies and strategies to overcome resistance in biliary tract cancers
1年前
已完结
Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor
1年前
已完结
皖公网安备34019202002308
